Published Guidance, NICE advice and quality standards
Showing 1 to 7 of 7
Title | Reference number | Published | Last updated |
---|---|---|---|
Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimen | TA515 | ||
Cabozantinib for treating medullary thyroid cancer | TA516 | ||
Brodalumab for treating moderate to severe plaque psoriasis | TA511 | ||
Tivozanib for treating advanced renal cell carcinoma | TA512 | ||
Obinutuzumab for untreated advanced follicular lymphoma | TA513 | ||
Autologous chondrocyte implantation using chondrosphere for treating symptomatic articular cartilage defects of the knee | TA508 | ||
Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancer | TA509 |